Recruiting Influenza Studies in Hialeah
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants i...
A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subty...
About Influenza Clinical Trials in Hialeah
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. It causes millions of illnesses and thousands of deaths annually. Prevention through vaccination is the primary strategy, with antiviral medications available for treatment.
There are currently 2 influenza clinical trials recruiting participants in Hialeah, FLORIDA. These studies are seeking a combined 3,045 participants. Research is being sponsored by BioNTech SE, AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Influenza Clinical Trials in Hialeah — FAQ
Are there influenza clinical trials in Hialeah?
Yes, there are 2 influenza clinical trials currently recruiting in Hialeah, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hialeah?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hialeah research site will contact you about next steps.
Are clinical trials in Hialeah free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hialeah studies also compensate for your time and travel.
What influenza treatments are being tested?
The 2 active trials in Hialeah are testing new therapies including novel drugs, biologics, and treatment approaches for influenza.
Data updated March 2, 2026 from ClinicalTrials.gov